Trials / Completed
CompletedNCT01685229
Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis
Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis (MERLOT)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 198 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This post-market study aims to compare health outcomes for Chronic Rhinosinusitis (CRS) patients treated with balloon sinus dilation (BSD) versus continued medical management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Balloon sinus dilation | Subjects electing continued medical therapy group will not have balloon sinus dilation intervention. Subjects electing balloon sinus dilation group will have balloon sinus dilation intervention. |
| DRUG | Medical Management | Subjects who select to continue on medical management rather than have a BSD procedure. |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2015-04-01
- Completion
- 2015-08-01
- First posted
- 2012-09-14
- Last updated
- 2024-07-12
- Results posted
- 2019-05-13
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01685229. Inclusion in this directory is not an endorsement.